MDLN
Medline Inc.
Surgical & Medical Instruments & Apparatus- 売上
- $28.4bn
- 時価総額
- $31.7bn
株価 $39.12 · 100株 3,912円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $23.2bn | $25.5bn | $28.4bn |
| 成長率 | — | 9.8% | 11.5% |
| 総利益 | $5.9bn | $7.0bn | $7.5bn |
| 総利益率 | 25.3% | 27.3% | 26.4% |
| 販管費 | $3.9bn | $4.1bn | $4.5bn |
| 販管費率 | 16.6% | 16.1% | 15.9% |
| 営利 | $1.3bn | $2.1bn | $2.2bn |
| 営利率 | 5.4% | 8.4% | 7.8% |
| 純利益 | — | — | $1.2bn |
| PBR | — | — | 3.0 |
| PSR | 1.4 | 1.2 | 1.1 |
| PGPR | 5.4 | 4.5 | 4.2 |
| PER | — | — | 27 |
| ﾈｯﾄｷｬｯｼｭ | — | ▲$16.3bn | ▲$10.6bn |
| EV/EBITDA | 14.4 | 15.4 | 13.1 |
| Rule of 40 | — | 18% | 19% |
| セールス効率 | — | 453% | 130% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）